We observed a clear trend between the zygosity status and the sensitivity to PLX4720 treatment ( Fig 4B ), similar to the findings of Halaban et al.
← all excerpts
Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma.
1
—
—